טוען...
MERS-CoV spike protein: Targets for vaccines and therapeutics
The disease outbreak caused by Middle East respiratory syndrome coronavirus (MERS-CoV) is still ongoing in the Middle East. Over 1700 people have been infected since it was first reported in September 2012. Despite great efforts, licensed vaccines or therapeutics against MERS-CoV remain unavailable....
שמור ב:
| הוצא לאור ב: | Antiviral Res |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113765/ https://ncbi.nlm.nih.gov/pubmed/27468951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.07.015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|